Search results

Page results

• National Hospital for Neurology and Neurosurgery at Cleveland Street

  The National Hospital for Neurosurgery at Cleveland Street opened its doors to patients on 4 April 2016. This brand new centre was developed to provide a new home for our Pain Management Centre, a nationally recognized centre of excellence for people with longstanding pain. Set over two floors the centre has group rooms and consulting clinic rooms as well as procedure rooms.Some multiple sclerosis clinics and outpatient appointments for the National Prion Clinic are also held at the centre.

• MENO.pause app launched to help clinicians manage patients’ menopause symptoms

  Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.

• BBC documentary featuring UCLH clinicians highlights harms of ultra-processed food

  A BBC One documentary featuring clinicians at UCLH which airs this Thursday highlights the harm to the body and brain caused by ultra-processed food.

• Covid-19 vaccine: Common stroke symptoms must be ‘urgently evaluated’

  UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.

• John McGrath

  John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.

• Drug combination could be new lupus treatment

  A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.

• Next-generation treatment for multiple myeloma shows early promise

  Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.

• SUMMIT Study early results feature in The Guardian

  A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.

• Getting to Grips with Anxiety - Two-part online workshop

  This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.

• 'Gamechanger' drug for treating obesity cuts body weight by 20%

  In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.